← Back to TCM Global · All articles
2026-10-23
At the 2026 'Big Food Concept' forum in Xi'an (October 16-18), Associate Professor Cao Cui of Xi'an Polytechnic University presented research on efficient preparation of rare ginsenosides — including a route that matters commercially: metal-salt-catalyzed directed conversion of ginsenoside Rb1.
Rare saponins (Rg3, Rg5, Rk1, CK) barely exist in raw ginseng. Three industrial routes compete:
The reported work uses metal salt catalysis to direct Rb1's conversion toward target rare saponins, paired with optimized separation and purification of Rg3 and Rg5. Directed conversion means higher selectivity — less waste, more target compound.
The research went further: sulfation and fatty-acylation modifications of the prepared saponins — chemically decorating the molecules to alter their properties. Then came the testing: modified products were compared for effects on breast cancer cell proliferation, colony formation and migration.
Key result: some modified products showed good proliferation-inhibition activity — but structural modification did not improve every measured metric. The modification groups and resulting molecular changes had differing, sometimes unexpected biological effects.
This is a valuable negative-space result: it maps which structural changes help, which don't — exactly the structure-activity relationship data that turns chemistry into drug and ingredient discovery.
The rare saponin supply chain is being built from three directions at once — and academic catalysis work like this ensures the chemistry keeps getting cheaper, greener and more selective. The lab-to-shelf pipeline is alive and compounding.
Explore more Eastern wellness wisdom at TCM Global.